Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment?

San-Miguel, J.F. (Jesús F.)

Authors:

San-Miguel, J.F. (Jesús F.)

Keywords:

Bortezomib
Multiple myeloma
Humans
Antineoplastic agents

Issue Date:

Jan-2014

Publisher:

Ferrata Storti Foundation

ISSN:

0390-6078

Citation:

San Miguel JF. Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment?. Haematologica. 2014 Jan;99(1):5-6

Abstract

Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.

URI:

https://hdl.handle.net/10171/36415

DOI:

http://dx.doi.org/10.3324/haematol.2013.100982

Appears in Collections:

DA - CIMA - Hemato-oncología - Mieloma - Artículos de Revista

Files in This Item:

File

0990005.pdf

Description

Size

104.79 kB

Format

Adobe PDF

View/Open

Statistics and impact

Statistics

0 citas en

Google Scholar

Show full item record